$481 Million is the total value of Ghost Tree Capital, LLC's 66 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CLVS | New | CLOVIS ONCOLOGY INCcall | $28,183,000 | – | 301,000 | +100.0% | 5.86% | – |
| PTLA | New | PORTOLA PHARMACEUTICALS INCput | $22,468,000 | – | 400,000 | +100.0% | 4.67% | – |
| MRK | New | MERCK & CO INCcall | $12,818,000 | – | 200,000 | +100.0% | 2.66% | – |
| GWPH | New | GW PHARMACEUTICALS PLCads | $12,531,000 | – | 125,000 | +100.0% | 2.60% | – |
| NVRO | New | NEVRO CORP | $12,281,000 | – | 165,000 | +100.0% | 2.55% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INC | $12,167,000 | – | 100,000 | +100.0% | 2.53% | – |
| ENDP | New | ENDO INTL PLC | $8,378,000 | – | 750,000 | +100.0% | 1.74% | – |
| JUNO | New | JUNO THERAPEUTICS INC | $8,220,000 | – | 275,000 | +100.0% | 1.71% | – |
| INSM | New | INSMED INC | $8,151,000 | – | 475,000 | +100.0% | 1.69% | – |
| EXEL | New | EXELIXIS INCput | $7,389,000 | – | 300,000 | +100.0% | 1.54% | – |
| TSRO | New | TESARO INC | $6,993,000 | – | 50,000 | +100.0% | 1.45% | – |
| FXB | New | CURRENCYSHS BRIT POUND STERbrit pound ste | $6,455,000 | – | 50,900 | +100.0% | 1.34% | – |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $6,374,000 | – | 150,000 | +100.0% | 1.32% | – |
| ITCI | New | INTRA CELLULAR THERAPIES INCcall | $6,210,000 | – | 500,000 | +100.0% | 1.29% | – |
| ALXN | New | ALEXION PHARMACEUTICALS INCcall | $5,475,000 | – | 45,000 | +100.0% | 1.14% | – |
| GILD | New | GILEAD SCIENCES INC | $5,309,000 | – | 75,000 | +100.0% | 1.10% | – |
| KITE | New | KITE PHARMA INCcall | $5,184,000 | – | 50,000 | +100.0% | 1.08% | – |
| AIMT | New | AIMMUNE THERAPEUTICS INC | $5,140,000 | – | 250,000 | +100.0% | 1.07% | – |
| ATRA | New | ATARA BIOTHERAPEUTICS INC | $4,900,000 | – | 350,000 | +100.0% | 1.02% | – |
| VRAY | New | VIEWRAY INC | $4,853,000 | – | 750,000 | +100.0% | 1.01% | – |
| ARGX | New | ARGENX SEsponsored adr | $4,163,000 | – | 196,287 | +100.0% | 0.86% | – |
| AXGT | New | AXOVANT SCIENCES LTD | $4,058,000 | – | 175,000 | +100.0% | 0.84% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $4,043,000 | – | 550,000 | +100.0% | 0.84% | – |
| NEOS | New | NEOS THERAPEUTICS INC | $3,650,000 | – | 500,000 | +100.0% | 0.76% | – |
| ALDR | New | ALDER BIOPHARMACEUTICALS INC | $2,863,000 | – | 250,000 | +100.0% | 0.60% | – |
| SNDX | New | SYNDAX PHARMACEUTICALS INC | $2,794,000 | – | 200,000 | +100.0% | 0.58% | – |
| RVNC | New | REVANCE THERAPEUTICS INC | $2,357,000 | – | 89,295 | +100.0% | 0.49% | – |
| QTNT | New | QUOTIENT LTD | $2,208,000 | – | 300,000 | +100.0% | 0.46% | – |
| BOLD | New | AUDENTES THERAPEUTICS INC | $957,000 | – | 50,000 | +100.0% | 0.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.